Comparison of animal and human blood for in vitro dynamic thrombogenicity testing of biomaterials
- PMID: 35866431
- PMCID: PMC9669094
- DOI: 10.1111/aor.14366
Comparison of animal and human blood for in vitro dynamic thrombogenicity testing of biomaterials
Abstract
Background: To determine suitable alternatives to human blood for in vitro dynamic thrombogenicity testing of biomaterials, four different animal blood sources (ovine, bovine, and porcine blood from live donors, and abattoir porcine blood) were compared to fresh human blood.
Methods: To account for blood coagulability differences between individual donors and species, each blood pool was heparinized to a donor-specific concentration immediately before testing in a dynamic flow loop system. The target heparin level was established using a static thrombosis pre-test. For dynamic testing, whole blood was recirculated at room temperature for 1 h at 200 ml/min through a flow loop containing a single test material. Four materials with varying thrombotic potentials were investigated: latex (positive control), polytetrafluoroethylene (PTFE) (negative control), silicone (intermediate thrombotic potential), and high-density polyethylene (HDPE) (historically thromboresistant). Thrombus weight and surface area coverage on the test materials were quantified, along with platelet count reduction in the blood.
Results: While donor-specific heparin levels varied substantially from 0.6 U/ml to 7.0 U/ml among the different blood sources, each source was able to differentiate between the thrombogenic latex and the thromboresistant PTFE and HDPE materials (p < 0.05). However, only donor ovine and bovine blood were sensitive enough to differentiate an increased response for the intermediate thrombotic silicone material compared to PTFE and HDPE.
Conclusions: These results demonstrated that multiple animal blood sources (particularly donor ovine and bovine blood) may be suitable alternatives to fresh human blood for dynamic thrombogenicity testing when appropriate control materials and donor-specific anticoagulation levels are used.
Keywords: animal blood sources; blood flow loop; human blood; in vitro testing; platelets; thrombogenicity; thrombosis.
Published 2022. This article is a U.S. Government work and is in the public domain in the USA.
Figures







Similar articles
-
Development of a large diameter in vitro flow loop thrombogenicity test system.Artif Organs. 2025 Jan;49(1):65-73. doi: 10.1111/aor.14852. Epub 2024 Sep 2. Artif Organs. 2025. PMID: 39221585 Free PMC article.
-
Effect of Temperature on Thrombogenicity Testing of Biomaterials in an In Vitro Dynamic Flow Loop System.ASAIO J. 2023 Jun 1;69(6):576-582. doi: 10.1097/MAT.0000000000001897. Epub 2023 Feb 27. ASAIO J. 2023. PMID: 36848878 Free PMC article.
-
An In Vitro Blood Flow Loop System for Evaluating the Thrombogenicity of Medical Devices and Biomaterials.ASAIO J. 2020 Feb;66(2):183-189. doi: 10.1097/MAT.0000000000000958. ASAIO J. 2020. PMID: 30807378 Free PMC article.
-
Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity.J Biomater Sci Polym Ed. 1993;4(3):217-34. doi: 10.1163/156856293x00537. J Biomater Sci Polym Ed. 1993. PMID: 8476792 Review.
-
In Vitro Thrombogenicity Testing of Biomaterials.Adv Healthc Mater. 2019 Nov;8(21):e1900527. doi: 10.1002/adhm.201900527. Epub 2019 Oct 15. Adv Healthc Mater. 2019. PMID: 31612646 Review.
Cited by
-
Designing an experimental method for assessing biocompatibility of circuit coatings using biomarkers for platelet activation during cardiopulmonary bypass.J Extra Corpor Technol. 2024 Jun;56(2):37-44. doi: 10.1051/ject/2024003. Epub 2024 Jun 18. J Extra Corpor Technol. 2024. PMID: 38888546 Free PMC article.
-
Molecular Biomarkers for In Vitro Thrombogenicity Assessment of Medical Device Materials.J Biomed Mater Res B Appl Biomater. 2024 Oct;112(10):e35491. doi: 10.1002/jbm.b.35491. J Biomed Mater Res B Appl Biomater. 2024. PMID: 39340365 Free PMC article.
-
Development of a large diameter in vitro flow loop thrombogenicity test system.Artif Organs. 2025 Jan;49(1):65-73. doi: 10.1111/aor.14852. Epub 2024 Sep 2. Artif Organs. 2025. PMID: 39221585 Free PMC article.
-
Alternative Anticoagulant Strategy to Improve the Test Sensitivity of ASTM F2888-19 Standard for Platelet and Leukocyte Count Assay.J Biomed Mater Res B Appl Biomater. 2024 Dec;112(12):e35514. doi: 10.1002/jbm.b.35514. J Biomed Mater Res B Appl Biomater. 2024. PMID: 39578236 Free PMC article.
-
In Vitro Thrombogenicity Testing of Biomaterials in a Dynamic Flow Loop: Effects of Length and Quantity of Test Samples.J Med Device. 2023 Sep 1;17(3):031003. doi: 10.1115/1.4062863. Epub 2023 Jul 25. J Med Device. 2023. PMID: 37554290 Free PMC article.
References
-
- Wiper A, Hashmi I, Srivastava V, Shaktawat S, Sogliani F, Tang G, et al. Guide wire thrombus formation during trans-femoral TAVI. Cardiovasc Revasc Med 2014;15(6–7):360–1. - PubMed
-
- Chin T, Priyesh P, Islam AM. A novel approach to extraction of a large thrombus on the intraventricular guide-wire during transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2017;89(3):495–8. - PubMed
-
- Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012;125(24):3038–47. - PubMed
-
- Li S, Henry JJ. Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 2011;13:451–75. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical